These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10993685)

  • 1. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
    Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
    J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
    Evert BO; Schelhaas J; Fleischer H; de Vos RA; Brunt ER; Stenzel W; Klockgether T; Wüllner U
    Clin Neuropathol; 2006; 25(6):272-81. PubMed ID: 17140157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
    Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
    Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranuclear aggregation of nonexpanded ataxin-3 in marinesco bodies of the nonhuman primate substantia nigra.
    Kettner M; Willwohl D; Hubbard GB; Rüb U; Dick EJ; Cox AB; Trottier Y; Auburger G; Braak H; Schultz C
    Exp Neurol; 2002 Jul; 176(1):117-21. PubMed ID: 12093088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
    Hayashi M; Kobayashi K; Furuta H
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
    Perez MK; Paulson HL; Pittman RN
    Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.
    Colomer Gould VF
    NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.
    Schmidt T; Landwehrmeyer GB; Schmitt I; Trottier Y; Auburger G; Laccone F; Klockgether T; Völpel M; Epplen JT; Schöls L; Riess O
    Brain Pathol; 1998 Oct; 8(4):669-79. PubMed ID: 9804376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
    Takahashi J; Tanaka J; Arai K; Funata N; Hattori T; Fukuda T; Fujigasaki H; Uchihara T
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):369-76. PubMed ID: 11305872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Furusho K; Yoshizawa T; Shoji S
    Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions.
    Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T
    Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD.
    Jana NR; Nukina N
    Neurotox Res; 2004; 6(7-8):523-33. PubMed ID: 15639784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.